YOU WERE LOOKING FOR :Pharmaceutical Marketing
Essays 181 - 210
so this is a good response to get the companys name and image into the minds of those who will prescribe the Merck treatments (Arn...
In ten pages this paper compares these two pharmaceutical firms in terms of sales, R and D expenditures, assets, and financial per...
In ten pages this paper discusses Medicare and the financial problems associated with supplying pharmaceutical benefits across the...
In ten pages this report examines a pharmaceutical corporate giant in a discussion of sales, financial performance, change, opport...
This pharmaceutical company is examined in ten pages in terms of the company itself, its subdivisons, consumer expectations, and a...
In fourteen pages this paper discusses the global pharmaceutical industry and the World Health Organization's efforts to combat va...
In fifteen pages this paper examines how developing nations are affected by the partnership between global pharmaceutical manufact...
In five pages this paper discusses the U.S. pharmaceutical company opening of a North Africa and Middle East regional office in an...
In five pages this report considers the pharmaceutical industry in an examination of world travel and international management wit...
In five pages this report considers how the pharmaceutical industry has benefited from technological development in this considera...
In fifty pages this paper discusses the necessary collaboration between the World Health Organization and the pharmaceuticals indu...
EVA = Net Operating Profit after Taxes - [Capital x Cost of Capital] This approach was intended to encourage managers to lo...
Competition became fierce with more than 1,000 applications for generic drugs in less than a year (Barr Pharmaceutical company, 20...
the salespeople, not to mention the third-party vendors who might be involved with the manufacture and distribution of the product...
or tested will never make it to market due to ineffective results, the development of side effects or other influencing criteria. ...
his own (Irving and Verdin, 2004). The FDA Administration tried to immediately distance itself from the regulators comments but th...
90bpm are of particular concern and associated with the worst outcomes but even resting heart rates exceeding 60bpm are reason for...
work toward a shared future" (p. 30). The mission of the XYZ Company is to bring the health-giving benefits of biotechnology to ...
article provides a polite, superficial look at the problem. 4. This is a financial issue. IV. Conclusion This article should...
grew from an average of seven in 1993 to an average of eleven in 2000 to an average of twelve in 2004 (Critser, 2007). At the tim...
likely not endear the FDA to elderly people who at this point cannot afford medication and are forced to go over the border to pur...
is the best product, [healthcare providers] will just use a cheaper product, and then if it doesnt work, theyll go to your product...
do, in fact, demonstrate an phenomenal increase over time in the number of prescriptions that the typical American uses. This num...
18.5 percent profit margin, more than four times that of all other industries" (Barry, 2002, May). With that money the drug indust...
not in conflict with models of corporate governance such as Milton Friedmans shareholder wealth maximisation model. Other interest...
invested equity is larger than the required equity rate of return (Johnson, 2002-2003). The DCF method is used when prospective di...
the "government should subsidize prescription drug spending for all 40 million Americans over the age of 65 - whether they need it...
allow the two figures to be taken and then assess. As there are different patterns in different industries we will choose two indi...
a health crisis and this takes priority (Legal Information Institute, 2005). Nonetheless, if Gentura offers the drug at a price b...
Two obvious questions linked with personalized medicine are: * Who can receive such personalized treatment? * Who pays for that pe...